P

Inventor

WOO JONG SOO

KR35 patents
⚠️ This page may combine multiple inventors who share the name “WOO JONG SOO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HANMI PHARM IND CO LTD

19 patents
US6039981AMar 21, 2000

Antifungal oral composition containing itraconazole and process for preparing same

HANMI PHARM IND CO LTD82 citations93
US9220704B2Dec 29, 2015

Composite formulation comprising a tablet encapsulated in a hard capsule

HANMI PHARM IND CO LTD7 citations83
US9283218B2Mar 15, 2016

Solid dispersion with improved solubility comprising tetrazole derivative as an active ingredient

HANMI PHARM IND CO LTD3 citations73
US6936625B2Aug 30, 2005

Amlodipine camsylate and method for preparing thereof

HANMI PHARM IND CO LTD6 citations73
US9931406B2Apr 3, 2018

Pharmaceutical composition comprising amide derivative inhibiting the growth of cancer cells and non-metallic salt lubricant

HANMI PHARM IND CO LTD2 citations72
US9867801B2Jan 16, 2018

Amorphous solid dispersion comprising taxane, tablet comprising the same, and method for preparing the same

HANMI PHARM IND CO LTD2 citations68
US11090299B2Aug 17, 2021

Oral solid formulation containing irinotecan and method of preparing the same

HANMI PHARM IND CO LTD0 citations54
US7759368B2Jul 20, 2010

Sustained release composition for oral administration of niacin

HANMI PHARM IND CO LTD0 citations52
US9549936B2Jan 24, 2017

Method for preparing dry powder for inhalation formulation comprising salmeterol xinafoate, fluticasone propionate and tiotropium bromide

HANMI PHARM IND CO LTD0 citations51
US9486528B2Nov 8, 2016

Stable pharmaceutical formulation for oral administration comprising levocetirizine or a pharmaceutically acceptable salt thereof, and montelukast or a pharmaceutically acceptable salt thereof

HANMI PHARM IND CO LTD0 citations51
US9283232B2Mar 15, 2016

Dry powder for inhalation formulation comprising salmeterol xinafoate, fluticasone propionate and tiotropium bromide, and method for preparing same

HANMI PHARM IND CO LTD0 citations51
US11052048B2Jul 6, 2021

Esomeprazole-containing complex capsule and preparation method therefor

HANMI PHARM IND CO LTD0 citations49
US10946003B2Mar 16, 2021

Formulation having improved pH-dependent drug-release characteristics, containing esomeprazole or pharmaceutically acceptable salt thereof

HANMI PHARM IND CO LTD0 citations49
US9801876B2Oct 31, 2017

Complex granule formulation having improved stability comprising levocetirizine and montelukast

HANMI PHARM IND CO LTD0 citations49
US9833413B2Dec 5, 2017

Pharmaceutical combination formulation comprising amlodipine, losartan and rosuvastatin

HANMI PHARM IND CO LTD0 citations45
US7704526B2Apr 27, 2010

Sustained release composition for oral administration of drugs

HANMI PHARM IND CO LTD0 citations43
US7485326B2Feb 3, 2009

Oral microemulsion composition comprising biphenyldimethyldicarboxylate and silybin

HANMI PHARM IND CO LTD0 citations43
US10434067B2Oct 8, 2019

Composite formulation for oral administration comprising ezetimibe and rosuvastatin

HANMI PHARM IND CO LTD0 citations40
US10034862B2Jul 31, 2018

Solid pharmaceutical composition comprising amlodipine and losartan

HANMI PHARM IND CO LTD0 citations35

PO HANG IRON & STEEL

3 patents

POSCO

3 patents

WOO JONG SOO

3 patents

HANMI PHARM IND LTD

1 patent

LEE CHANG HYUN

1 patent

NOVARTIS AG

1 patent

HAMMI PHARM CO LTD

1 patent

KIM YONG IL

1 patent

HANMS PHARM CO LTD

1 patent

(unassigned)

1 patent